HOME >> BIOLOGY >> NEWS
JCI table of contents, 1 June 2004

Atherosclerosis Treatment Needs to Go with the Flow

Branch points in the arteries are a common area of atherosclerotic disease, resulting in the occlusion of both branches. These branch points can generally be defined as a main branch and a side branch, and, in treating the disease, the question of what is the optimal course of action, opening the main branch, the side branch, or both, remains uncertain. Studies have shown that using a stent to open a blocked blood vessel is generally more successful that balloon angioplasty, when one is treating a lesion in non-bifurcated area. Current data, however, indicate no such superiority in the use of stents to treat lesions in branching passages. Yoram Richter and colleagues, from HarvardM.I.T. Division of Health Sciences and Technology, provide a hemodynamic analysis (an analysis of the forces of blood flow) in the region of the bifurcated vasculature to show that stenting of both passages results in a blood flow pattern that is inherently harmful to the main branch, and results in rapid re-occlusion of the main branch. To investigate this system, the authors developed a new dynamic bench top fluid mechanical model system. This system provides a major advance over previous static models by allowing not only the prediction of areas in the blood vessels likely to be damaged, but also by reflecting the true active nature of the arterial system that compensates for and minimizes any disturbance. The authors further tested their in vitro predictions in an animal model, and, in seeing in the animals what was predicted to occur from their bench top model, established the strength of their in vitro modeling system. This study provides an explanation for why stenting in forked blood vessel regions has had a low success rate, and also provides a direction for appropriate treatment of these commonly blocked regions.

An accompanying commentary from R. Wayne Alexander at Emory University, provides a detaile
'"/>

Contact: Laurie Goodman
press_releases@the-jci.org
212-342-4259
Journal of Clinical Investigation
1-Jun-2004


Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology news :

1. Chemical engineering grad students will take notable national awards
2. New study indicates arsenic could be suitable as first-line treatment in type of leukaemia
3. JCI table of contents September 15, 2004
4. JCI table of contents: 1 September, 2004
5. Anti-cancer compound in vegetables found to block late-stage breast-cancer cell growth
6. JCI table of contents, 16 August, 2004
7. JCI table of contents, 2 August, 2004
8. When male fish hum, females swim in, thanks to hormones, adaptable hearing
9. JCI table of contents, 1 July 2004
10. Search and destroy protein turns tables on HIV
11. JCI table of contents, 15 June 2004

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/5/2018)... ... December 04, 2018 , ... The new ... in the development of innovative solutions for which high-speed imaging is a necessary ... microfluidics to industrial machinery and instrumentation, allowing partner companies to dedicate their resources ...
(Date:11/27/2018)... ... November 27, 2018 , ... Earthres Group, ... as Chief Operating Officer (COO). Dave joins the executive leadership team at ... internal functions. Dave will also serve in a key strategic role by ...
(Date:11/27/2018)... ... November 27, 2018 , ... Victrex has designed a ... a broader range of usage temperature compared to existing polymers such as PCTFE. ... VICTREX CT™ 200 for dynamic sealing applications where gases such as LNG* are ...
Breaking Biology News(10 mins):
(Date:11/7/2018)... ... November 07, 2018 , ... Since September of this year, ... of the adult tissue stem cell counting problem in stem cell medicine and ... intensifying this effort with new educational publications and presentations at clinical trial supply ...
(Date:11/6/2018)... Nev. (PRWEB) , ... November 06, 2018 , ... ... native mobile app for clinical trial data collection and management. TrialKit ™, ... users with compatible generation devices can quickly and easily sign in to the ...
(Date:11/5/2018)... ... November 05, 2018 , ... USARAD Holdings Inc., the leading ... several healthcare VC firms announces at Distributed Health 2018 conference November 5-6 (Nashville, ... tokens and obtaining its first radiology interpretations, one of the first known true ...
(Date:11/5/2018)... (PRWEB) , ... November 05, 2018 , ... ... for access to 2Blades’ Transcription Activator Like (TAL) effector code technology for applications ... commercial uses of the technology in plants. Since its discovery in 2009, the efficacy ...
Breaking Biology Technology:
Cached News: